These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26028227)

  • 1. Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma.
    Huertas A; Baumann AS; Saunier-Kubs F; Salleron J; Oldrini G; Croisé-Laurent V; Barraud H; Ayav A; Bronowicki JP; Peiffert D
    Radiother Oncol; 2015 May; 115(2):211-6. PubMed ID: 26028227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY; Lee Y; McLean K; Leggett D; Hodgkinson P; Fawcett J; Mott R; Stuart K; Pryor D
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e194-e202. PubMed ID: 32345457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
    Gerum S; Heinz C; Belka C; Walter F; Paprottka P; De Toni EN; Roeder F
    Radiat Oncol; 2018 May; 13(1):100. PubMed ID: 29843752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E; Schultheiss M; Bettinger D; Maruschke L; Neeff HP; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
    Radiat Oncol; 2017 Jul; 12(1):116. PubMed ID: 28701219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
    Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
    J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
    Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study].
    Scher N; Janoray G; Riet FG; Le Bayon AG; Debbi K; Lévy S; Louisot P; Garaud P; Chajon E; Barillot I; Salamé É; de Crevoisier R; Chapet S; Calais G
    Cancer Radiother; 2019 Apr; 23(2):104-115. PubMed ID: 30952560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization.
    Kang JK; Kim MS; Cho CK; Yang KM; Yoo HJ; Kim JH; Bae SH; Jung DH; Kim KB; Lee DH; Han CJ; Kim J; Park SC; Kim YH
    Cancer; 2012 Nov; 118(21):5424-31. PubMed ID: 22570179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity.
    Bibault JE; Dewas S; Vautravers-Dewas C; Hollebecque A; Jarraya H; Lacornerie T; Lartigau E; Mirabel X
    PLoS One; 2013; 8(10):e77472. PubMed ID: 24147002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.
    Lazarev S; Hardy-Abeloos C; Factor O; Rosenzweig K; Buckstein M
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2077-2083. PubMed ID: 30088143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
    Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
    Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma.
    Seo YS; Kim MS; Yoo SY; Cho CK; Choi CW; Kim JH; Han CJ; Park SC; Lee BH; Kim YH; Lee DH
    J Surg Oncol; 2010 Sep; 102(3):209-14. PubMed ID: 20740576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
    Guarneri A; Franco P; Trino E; Campion D; Faletti R; Mirabella S; Gaia S; Ragona R; Diotallevi M; Saracco G; Salizzoni M; Ricardi U; Carucci P
    Med Oncol; 2016 Oct; 33(10):104. PubMed ID: 27566310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma.
    Meng M; Wang H; Zeng X; Zhao L; Yuan Z; Wang P; Hao X
    Drug Discov Ther; 2015 Oct; 9(5):372-9. PubMed ID: 26632546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients.
    Su TS; Liang P; Lu HZ; Liang J; Gao YC; Zhou Y; Huang Y; Tang MY; Liang JN
    J Surg Oncol; 2016 Feb; 113(2):181-7. PubMed ID: 26799260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.